tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of William Plovanic, 217 are a BUY (84.11%), 41 are a HOLD (15.89%).
Analyst William Plovanic, currently employed at CANACCORD, carries an average stock price target met ratio of 53.41% that have a potential upside of 27.11% achieved within 113 days.
William Plovanic’s has documented 485 price targets and ratings displayed on 27 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TNDM, Tandem Diabetes Care at 27-Feb-2025.
Analyst best performing recommendations are on CVRX (CVRX).
The best stock recommendation documented was for CVRX (CVRX) at 12/21/2023. The price target of $30 was fulfilled within 5 days with a profit of $4.67 (18.44%) receiving and performance score of 36.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$0.74
$0.52 (236.36%)
$1
1 years 6 months 25 days ago
(08-Aug-2023)
5/8 (62.5%)
$0.1 (15.63%)
61
Hold
$1.5
$1.28 (581.82%)
2 years 6 months 17 days ago
(16-Aug-2022)
1/2 (50%)
$0.05 (3.45%)
2
Buy
$1.5
$1.28 (581.82%)
2 years 8 months 9 days ago
(24-Jun-2022)
1/5 (20%)
$0.96 (177.78%)
27
Sell
$19
3 years 3 months 21 days ago
(12-Nov-2021)
0/2 (0%)
$3.71 (16.84%)
Hold
$23
$21.36 (1302.44%)
$30
3 years 11 months 14 days ago
(19-Mar-2021)
0/3 (0%)
$4.37 (22.18%)
Which stock is William Plovanic is most bullish on?
Which stock is William Plovanic is most reserved on?
What Year was the first public recommendation made by William Plovanic?
